tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market

CytoMed Therapeutics Limited (GDTC) Financial Statements

Compare
8 Followers

CytoMed Therapeutics Limited Financial Overview

CytoMed Therapeutics Limited's market cap is currently $28.50M. The company's EPS TTM is $-0.196; its P/E ratio is ―; CytoMed Therapeutics Limited is scheduled to report earnings on May 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 290.56K---$ 0.00
Gross Profit$ 213.09K---$ 0.00
Operating Income$ -2.91M----
EBITDA$ -2.94M----
Net Income$ -3.13M----
Balance Sheet
Cash & Short-Term Investments$ 9.00M$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 12.37M----
Total Debt$ 448.02K----
Net Debt$ -8.55M----
Total Liabilities$ 1.12M----
Stockholders' Equity$ 8.49M$ 0.00$ 0.00$ 0.00$ 0.00
Cash Flow
Free Cash Flow-----
Operating Cash Flow$ -2.60M----
Investing Cash Flow-----
Financing Cash Flow$ 8.27M----
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History

CytoMed Therapeutics Limited Debt to Assets

CytoMed Therapeutics Limited Cash Flow

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis